Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ACTRIMS 2021 | Funding clinical studies in Latin America

Fernando Hamuy Diaz de Bedoya • 15 Feb 2021
ACTRIMS 2021
Multiple Sclerosis and Related Disorders

Fernando Hamuy Diaz de Bedoya, MD, PhD, National University of Asuncion, San Lorenzo, Paraguay, outlines the status of clinical trials in Latin America. Dr Hamuy Diaz de Bedoya serves as President of the Latin American Committee for Treatment and Research in Multiple Sclerosis (LACTRIMS): a non-profit association dedicated to developing MS research, treatment and teaching in Latin America. He discusses how LACTRIMS are financing projects to address funding difficulties. This interview took place during the ACTRIMS Forum 2021.

More from Fernando Hamuy Diaz de Bedoya

The demographics of MS in Latin America
1:33
The demographics of MS in Latin America
Fernando Hamuy Diaz de Bedoya • 15 Feb 2021

Related Videos

What are the key changes introduced in the 2024 revision of the McDonald diagnostic criteria for MS?
6:48
What are the key changes introduced in the 2024 revision of the McDonald diagnostic criteria for MS?
Mar Tintoré • 3 Jul 2026
Ovarian aging and long-term prognosis in women with multiple sclerosis
3:07
Ovarian aging and long-term prognosis in women with multiple sclerosis
Mar Tintoré • 3 Jul 2026
The emerging role of AI in the diagnosis and management of multiple sclerosis
1:55
The emerging role of AI in the diagnosis and management of multiple sclerosis
Celia Oreja-Guevara • 29 Jun 2026
Can selected patients with multiple sclerosis safely discontinue ocrelizumab?
3:15
Can selected patients with multiple sclerosis safely discontinue ocrelizumab?
Franz Felix Konen • 28 Jul 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals